Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chromogranin A (344-364) fragment

Known as: catestatin, chromogranin A (344-364) 
 
National Institutes of Health

Related topics

Related topics

3 relations
CHGA gene

Broader (2)

Chromogranin APeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.
Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular activities. Conflicting results have been… Expand
2012
2012
Chromogranin A-derived peptides are involved in innate immunity.
New endogenous antimicrobial peptides (AMPs) derived from chromogranin A (CgA) are secreted by nervous, endocrine and immune… Expand
2010
2010
Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea.
BACKGROUND Obstructive sleep apnea (OSA) is common in children and leads to multiple end-organ morbidities induced by the… Expand
2010
2010
Membrane structure and interactions of human catestatin by multidimensional solution and solid‐state NMR spectroscopy
Catestatin is a natural peptide of higher organisms including humans, with a wide variety of biological functions involved in… Expand
Highly Cited
2009
Highly Cited
2009
Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
We reported previously that chromogranin A (Chga) knockout (KO) mice are hypertensive and hyperadrenergic. Here we sought to… Expand
2004
2004
Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A
Previous modeling (PDB 1cfk) of the catecholamine release-inhibitory "catestatin" region of chromogranin A (CgA) suggested a beta… Expand
Highly Cited
2002
Highly Cited
2002
Modulatory Mechanism of the Endogenous Peptide Catestatin on Neuronal Nicotinic Acetylcholine Receptors and Exocytosis
The catestatin fragment of chromogranin A is the first known endogenous compound able to inhibit catecholamine release elicited… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
The novel chromogranin A fragment catestatin (bovine chromogranin A(344-364); RSMRLSFRARGYGFRGPGLQL) is a potent inhibitor of… Expand
2000
2000
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A352-372) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic…
The catecholamine release-inhibitory chromogranin A fragment catestatin (chromogranin A(344-364)) exhibits non-competitive… Expand
1998
1998
A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
Publisher Summary Proteolysis of chromogranin A takes place both within secretory granules and extracellularly, giving rise to… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE